GSK delivers 2009 EPS of 121.2p before major restructuring* and dividend of 61p (+4p)
- Strategy supports return to sales growth (+3%)
- Sustained R&D productivity; with further actions to improve returns

LONDON, UK I February 4, 2010 I GlaxoSmithKline's Unaudited Preliminary Results Announcement for the year ended 31st December 2009: Click here to read the press release

---